HU164525B - - Google Patents
Info
- Publication number
- HU164525B HU164525B HUTA1163A HUTA001163A HU164525B HU 164525 B HU164525 B HU 164525B HU TA1163 A HUTA1163 A HU TA1163A HU TA001163 A HUTA001163 A HU TA001163A HU 164525 B HU164525 B HU 164525B
- Authority
- HU
- Hungary
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP45124064A JPS4935635B1 (enExample) | 1970-12-28 | 1970-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU164525B true HU164525B (enExample) | 1974-02-28 |
Family
ID=14876047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUTA1163A HU164525B (enExample) | 1970-12-28 | 1971-12-23 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3819613A (enExample) |
| JP (1) | JPS4935635B1 (enExample) |
| BE (1) | BE777223A (enExample) |
| CA (1) | CA952102A (enExample) |
| DE (1) | DE2163790A1 (enExample) |
| FR (1) | FR2120040A1 (enExample) |
| HU (1) | HU164525B (enExample) |
| NL (1) | NL7117787A (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4157443A (en) * | 1976-11-11 | 1979-06-05 | Ciba-Geigy Corporation | V-Triazolyl-[4,5-d]-pyrimidines |
| US5155098A (en) * | 1989-06-09 | 1992-10-13 | Hoechst-Roussel Pharmaceuticals Inc. | N-heteroaryl-purin-6-amines, and pharmaceutical compositions and methods employing them |
| US5017578A (en) * | 1989-06-09 | 1991-05-21 | Hoechst-Roussel Pharmaceuticals Inc. | N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents |
| US5278150A (en) * | 1992-04-24 | 1994-01-11 | Whitby Research, Inc. | 2-hydrazoadenosines and their utility for the treatmeat of vascular conditions |
| DK62592D0 (enExample) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As | |
| US5589467A (en) * | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
| EP0704215A3 (en) * | 1994-06-02 | 1998-04-01 | Takeda Chemical Industries, Ltd. | Inhibitor of vascular permeability enhancer |
| WO1999017784A1 (en) | 1997-10-07 | 1999-04-15 | Regents Of The University Of California Corporation | Treating occlusive peripheral vascular disease and coronary disease with combinations of heparin and an adenoside a2 agonist, or with adenosine |
| US5972903A (en) * | 1997-10-07 | 1999-10-26 | Regents Of The University Of California Corporation | Method for promoting angiogenesis using heparin and adenosine |
| ME01072B (me) * | 2004-05-26 | 2012-10-20 | Inotek Pharmaceuticals Corp | Derivati purina kao agonisti receptora adenozina a1 i postupci za njihovu upotrebu |
| BRPI0619261A2 (pt) * | 2005-11-30 | 2011-09-27 | Inotek Pharmaceuticals Corp | derivados de purina e métodos de uso desses |
| JP2013516495A (ja) | 2010-01-11 | 2013-05-13 | イノテック ファーマシューティカルズ コーポレイション | 眼圧を低下させる組合せ、キット、および方法 |
| JP2013523739A (ja) | 2010-03-26 | 2013-06-17 | イノテック ファーマシューティカルズ コーポレイション | Ｎ６−シクロペンチルアデノシン（ｃｐａ）、ｃｐａ誘導体またはそれらのプロドラッグを用いてヒトにおける眼内圧を低下させる方法 |
| SMT201700377T1 (it) | 2012-01-26 | 2017-09-07 | Inotek Pharmaceuticals Corp | Polimorfi anidri di (2r,3s,4r,5r)-5-(6-(ciclopentilammino)-9h-purin-9-il)-3,4- diidrossitetraidrofuran-2-il)}metil nitrato e processi di sua preparazione |
| NZ630759A (en) | 2013-03-15 | 2017-07-28 | Inotek Pharmaceuticals Corp | Ophthalmic formulations comprising an a1 agonist |
| WO2020253870A1 (zh) * | 2019-06-21 | 2020-12-24 | 中国人民解放军军事科学院军事医学研究院 | 具有a2a腺苷受体激动剂活性的6-肼基腺苷类化合物 |
-
1970
- 1970-12-28 JP JP45124064A patent/JPS4935635B1/ja active Pending
-
1971
- 1971-12-22 DE DE19712163790 patent/DE2163790A1/de active Pending
- 1971-12-22 US US00211107A patent/US3819613A/en not_active Expired - Lifetime
- 1971-12-23 NL NL7117787A patent/NL7117787A/xx unknown
- 1971-12-23 CA CA130,987A patent/CA952102A/en not_active Expired
- 1971-12-23 BE BE777223A patent/BE777223A/xx unknown
- 1971-12-23 HU HUTA1163A patent/HU164525B/hu unknown
- 1971-12-27 FR FR7146835A patent/FR2120040A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| BE777223A (fr) | 1972-06-23 |
| FR2120040A1 (enExample) | 1972-08-11 |
| NL7117787A (enExample) | 1972-06-30 |
| US3819613A (en) | 1974-06-25 |
| DE2163790A1 (de) | 1972-07-20 |
| CA952102A (en) | 1974-07-30 |
| JPS4935635B1 (enExample) | 1974-09-25 |